Table 2 Analysis of N-glycans expressive signatures between T2DM cases and healthy controls across the four clusters.

From: Multi-block data integration analysis for identifying and validating targeted N-glycans as biomarkers for type II diabetes mellitus

Clusters

N-glycans

Univariate analysis

A

GP 32, GP 31, GP 34, GP 26, GP 24, GP 28, GP 30, GP 37, GP 36, GP 38, GP 19, GP 14, GP 20, GP 12, GP 18, GP 29

\(K = 16;k = 11,p < 0.05\)

B

GP 21, GP 8, GP 15, GP 3, GP 9, GP 1, GP 2, GP 7, GP 6, GP 11, GP 17, GP 10, GP 16, GP 13, GP 4, GP 5

\(K = 16;k = 8,p < 0.05\)

C

GP 39, GP 35, GP 27, GP 33

\(K = 4;k = 1,p < 0.05\)

D

GP 25, GP 22, GP 23

\(K = 3;k = 1,p < 0.05\)

  1. NB: Bold text indicates the glycan expression is significantly different between T2DM cases and healthy controls, compared at 5% level of significance.
Back to article page